Literatura académica sobre el tema "Malignant Cells - Molecular Characetrization"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Malignant Cells - Molecular Characetrization".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Malignant Cells - Molecular Characetrization"
Fredholm, Simon, Andreas Willerslev-Olsen, Özcan Met, Linda Kubat, Maria Gluud, Sarah L. Mathiasen, Christina Friese et al. "SATB1 in Malignant T Cells". Journal of Investigative Dermatology 138, n.º 8 (agosto de 2018): 1805–15. http://dx.doi.org/10.1016/j.jid.2018.03.1526.
Texto completoMiller, W. H. "Molecular Targets of Arsenic Trioxide in Malignant Cells". Oncologist 7, n.º 90001 (1 de abril de 2002): 14–19. http://dx.doi.org/10.1634/theoncologist.7-2004-14.
Texto completoMiller, Wilson H. "Molecular Targets of Arsenic Trioxide in Malignant Cells". Oncologist 7, S1 (abril de 2002): 14–19. http://dx.doi.org/10.1634/theoncologist.7-suppl_1-14.
Texto completoSuzme, R., J.-C. Tseng, B. Levin, S. Ibrahim, D. Meruelo y A. Pellicer. "Sindbis viral vectors target hematopoietic malignant cells". Cancer Gene Therapy 19, n.º 11 (7 de septiembre de 2012): 757–66. http://dx.doi.org/10.1038/cgt.2012.56.
Texto completoBALIS, M. EARL. "Adenosine Deaminase and Malignant Cells". Annals of the New York Academy of Sciences 451, n.º 1 (octubre de 1985): 142–49. http://dx.doi.org/10.1111/j.1749-6632.1985.tb27105.x.
Texto completoCairo, Gaetano, Paolo Vezzoni, Lidia Bardella, Luisa Schiaffonati, Emilia Rappocciolo, Sonia Levi, Paolo Arosio y Aldo Bernelli-Zazzera. "Regulation of ferritin synthesis in malignant and non-malignant lymphoid cells". Biochemical and Biophysical Research Communications 139, n.º 2 (septiembre de 1986): 652–57. http://dx.doi.org/10.1016/s0006-291x(86)80040-7.
Texto completoPostovit, Lynne-Marie, Elisabeth A. Seftor, Richard EB Seftor y Mary JC Hendrix. "Targeting Nodal in malignant melanoma cells". Expert Opinion on Therapeutic Targets 11, n.º 4 (20 de marzo de 2007): 497–505. http://dx.doi.org/10.1517/14728222.11.4.497.
Texto completoCheng, Sun-Long, Rosa Huang-Liu, Jin-Nan Sheu, Shui-Tein Chen, Supachok Sinchaikul y Gregory J. Tsay. "Toxicogenomics of A375 human malignant melanoma cells". Pharmacogenomics 8, n.º 8 (agosto de 2007): 1017–36. http://dx.doi.org/10.2217/14622416.8.8.1017.
Texto completoKatsoulidis, Efstratios, Surinder Kaur y Leonidas C. Platanias. "Deregulation of Interferon Signaling in Malignant Cells". Pharmaceuticals 3, n.º 2 (4 de febrero de 2010): 406–18. http://dx.doi.org/10.3390/ph3020406.
Texto completoToo, Catherine K. L., Christine Lee, Shirley M. Sangster y Peter W. Gout. "Malignant Progression of Rat Nb2 Lymphoma Cells". Cancer Genetics and Cytogenetics 110, n.º 2 (abril de 1999): 115–23. http://dx.doi.org/10.1016/s0165-4608(98)00191-5.
Texto completoTesis sobre el tema "Malignant Cells - Molecular Characetrization"
Endaya, Berwini B. "Detecting Proliferating Tumor Cells for their Molecular Characterisation". Thesis, Griffith University, 2016. http://hdl.handle.net/10072/367491.
Texto completoThesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Medical Science
Griffith Health
Full Text
Au, Wing-yan. "Pathogenesis and progression of malignant B cell neoplasms /". View the Table of Contents & Abstract, 2005. http://sunzi.lib.hku.hk/hkuto/record/B31540892.
Texto completoJoseloff, Elizabeth 1969. "AP-1 regulation during malignant progression of mouse keratinocyte cells". Diss., The University of Arizona, 1997. http://hdl.handle.net/10150/282562.
Texto completoKårehed, Karin. "Signal Transduction in Malignant Cells – Transformation, Activation and Differentiation". Doctoral thesis, Uppsala University, Department of Genetics and Pathology, 2006. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-6346.
Texto completoAll aspects of cell life are regulated by signal transduction mechanisms. This thesis describes the regulatory roles of a few key signal transduction molecules involved in three major biological responses. The studied pathways include platelet derived growth factor (PDGF)-BB induced transformation of murine fibroblasts, interferon (IFN)-γ stimulated monocyte activation and all-trans retinoic acid (ATRA) induced myeloid differentiation.
We found that intact phosphoinositide 3OH-kinase (PI3K) activity is essential in the signaling pathway that leads to the morphological alterations and migration pattern characteristic of PDGF-BB transformed NIH/sis and NIH/COL1A1 fibroblasts. Furthermore, our data indicated that the small Rho-GTPase, Rac1 is the predominant mediator of these signals downstream of PI3K.
The study of the IFN-γ induced activation of monocytic U-937 cells showed that upregulation of the high affinity receptor for IgG (FcγRI) is dependent on the coordination of several regulatory events: the PKR-mediated serine 727 phosphorylation of Stat1, the expression of the hematopoietic lineage specific transcription factor PU.I, and the activation of the NFκB pathway.
ATRA-induced differentiation and cell cycle arrest are impaired in U-937 sublines expressing phosphorylation deficient Stat1 (Stat1Y701F and Stat1S727A). The findings in paper III indicated that the expression pattern of the myeloid specific transcription factors Stat2, ICSBP and c/EBPε was altered in the sublines and that intact Stat1 activation is critical for maintaining the balance of the transcriptional network during ATRA induced terminal differentiation.
Finally, ATRA-induced differentiation and growth arrest were blocked by treatment with the IKKα/β inhibitor BMS345541 or by ectopic expression of the NFκB super repressor IκBα (S32A/S36A). The fact that IκB(AA) sublines differentiated normally in response to vitamin D3, showed that NFκB inhibition specifically affected ATRA induced responses. Notably we suggest that the activity of the NFκB pathway may interfere with the differentiation process via a direct effect on the RAR/RXR mediated transcription.
Bouralexis, Stelios. "Molecular mechanisms of Apo2L/TRAIL induced apoptosis in normal and malignant cells /". Title page, contents and synopsis only, 2003. http://web4.library.adelaide.edu.au/theses/09PH/09phb766.pdf.
Texto completoAu, Wing-yan y 區永仁. "Pathogenesis and progression of malignant B cell neoplasms". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2005. http://hub.hku.hk/bib/B45007676.
Texto completoSolomon, Cynthia 1974. "Mechanisms of 1,25-dihydroxyvitamin D resistance in tumor cells as they progress from the normal to the malignant phenotype". Thesis, McGill University, 2000. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=36710.
Texto completoCorradi, Giulia <1990>. "Molecular and functional characterization of the interplay between malignant and stromal cells in acute myeloid leukemia and myelodysplastic syndrome". Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2019. http://amsdottorato.unibo.it/8812/1/Corradi_Giulia_Tesi.pdf.
Texto completoLi, Ge. "Cell physiology, biochemistry, and molecular biology of 5-aminolevulinic acid-induced protoporphyrin IX in normal, immortalized, transfected, and malignant cells". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape17/PQDD_0005/NQ27837.pdf.
Texto completoEliasson, Pernilla. "Live and Let Die : Critical regulation of survival in normal and malignant hematopoietic stem and progenitor cells". Doctoral thesis, Linköpings universitet, Experimentell hematologi, 2009. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-52932.
Texto completoOn the day of the defence date the title of article II was "Hypoxia, via hypoxia-inducible factor (HIF)-1, mediates low cell cycle activity and preserves the engraftment potential of mouse hematopoietic stem cells" and one of the authors is no longer included in the article.
Libros sobre el tema "Malignant Cells - Molecular Characetrization"
T, Lynch Henry y Fusaro Ramon M, eds. Hereditary malignant melanoma. Boca Raton: CRC Press, 1991.
Buscar texto completoLynch, Henry T. y Ramon M. Fusaro. Hereditary Malignant Melanoma. Taylor & Francis Group, 2019.
Buscar texto completoLynch, Henry T. y Ramon M. Fusaro. Hereditary Malignant Melanoma. Taylor & Francis Group, 2019.
Buscar texto completoLynch, Henry T. y Ramon M. Fusaro. Hereditary Malignant Melanoma. Taylor & Francis Group, 2019.
Buscar texto completoLynch, Henry T. y Ramon M. Fusaro. Hereditary Malignant Melanoma. Taylor & Francis Group, 2019.
Buscar texto completoCapítulos de libros sobre el tema "Malignant Cells - Molecular Characetrization"
Hess, David A. y Alison L. Allan. "Migratory Strategies of Normal and Malignant Stem Cells". En Methods in Molecular Biology, 25–44. Totowa, NJ: Humana Press, 2011. http://dx.doi.org/10.1007/978-1-61779-145-1_2.
Texto completoPilarski, Linda M., Tony Reiman, Patrick M. Pilarski, F. William Orr y Andrew R. Belch. "The Malignant Hierarchy in Multiple Myeloma: Relationships between Malignant Cells and Bone Disease". En Bone Metastasis and Molecular Mechanisms, 109–38. Dordrecht: Springer Netherlands, 2004. http://dx.doi.org/10.1007/978-1-4020-2036-0_7.
Texto completoKizhakeyil, Atish, Mobashar Hussain Urf Turabe Fazil y Navin Kumar Verma. "Targeted Gene Silencing in Malignant Hematolymphoid Cells Using GapmeR". En Methods in Molecular Biology, 209–19. New York, NY: Springer US, 2020. http://dx.doi.org/10.1007/978-1-0716-0771-8_15.
Texto completoJalili-Nik, Mohammad, Amir R. Afshari, Khadijeh Mahboobnia, Paul C. Guest, Tannaz Jamialahmadi y Amirhossein Sahebkar. "Analysis of Cytotoxic Effects of in Malignant Glioblastoma Cells". En Methods in Molecular Biology, 361–69. New York, NY: Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-1558-4_26.
Texto completoMilosevic, Vladan, Reidunn J. Edelmann, Johanna Hol Fosse, Arne Östman y Lars A. Akslen. "Molecular Phenotypes of Endothelial Cells in Malignant Tumors". En Biomarkers of the Tumor Microenvironment, 31–52. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-98950-7_3.
Texto completoCherukuri, Paul y Steven A. Curley. "Use of Nanoparticles for Targeted, Noninvasive Thermal Destruction of Malignant Cells". En Methods in Molecular Biology, 359–73. Totowa, NJ: Humana Press, 2010. http://dx.doi.org/10.1007/978-1-60761-609-2_24.
Texto completoNeschadim, Anton y Jeffrey A. Medin. "Engineered Thymidine-Active Deoxycytidine Kinase for Bystander Killing of Malignant Cells". En Methods in Molecular Biology, 149–63. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-8922-5_12.
Texto completoWang, Yue J., Jennifer M. Bailey, Meritxell Rovira y Steven D. Leach. "Sphere-Forming Assays for Assessment of Benign and Malignant Pancreatic Stem Cells". En Methods in Molecular Biology, 281–90. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-62703-287-2_15.
Texto completoMimeault, Murielle y Surinder K. Batra. "Characterization of Nonmalignant and Malignant Prostatic Stem/Progenitor Cells by Hoechst Side Population Method". En Methods in Molecular Biology, 139–49. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-280-9_8.
Texto completoKüppers, Ralf, Markus Schneider y Martin-Leo Hansmann. "Laser-Based Microdissection of Single Cells from Tissue Sections and PCR Analysis of Rearranged Immunoglobulin Genes from Isolated Normal and Malignant Human B Cells". En Methods in Molecular Biology, 61–75. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9151-8_3.
Texto completoActas de conferencias sobre el tema "Malignant Cells - Molecular Characetrization"
Jeffress, Mara, Alain Beliveau, Eric Campeau, Joe Gray y Paul Yaswen. "Abstract B91: RNAi knockdown of Mek2, but not Mek1, increases proliferation of malignant and non‐malignant human breast cells". En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/1535-7163.targ-09-b91.
Texto completoDeeb, Kristin K., Song Liu, Wei Luo, Adam R. Karpf, Carl Morrison, Candace S. Johnson y Donald L. Trump. "Abstract 1288: Molecular features of endothelial cells isolated from benign and malignant prostatic tissues". En Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-1288.
Texto completoKaza, Niroop y Kevin A. Roth. "Abstract A34: Analysis of gossypol-induced cytotoxicity in malignant peripheral nerve sheath tumor cells." En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1535-7163.targ-11-a34.
Texto completoWang, Wei-Ting, James Catto y Mark Meuth. "Abstract B61: Differential response of normal and malignant urothelial cells to CHK1 and ATM inhibitors." En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-b61.
Texto completoKing, Trey, Mickeal Key, John Clifford, Jennifer Roberts Gill, Yoonjee Kim, Elahe Mahdavian, Urska Cvek et al. "Abstract A35: DNA microarray analysis of the effect of fusarochromanone on human malignant bladder cancer cells." En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1535-7163.targ-11-a35.
Texto completoDupéré‐Richer, Daphné, Luca Petruccelli, Hélène Retrouvey, Monica Dobocan, Miranda Tomenson, Filippa Pettersson y Wilson H. Miller. "Abstract A188: Proapoptoticversusprosurvival function of the MAP kinase p38 induced by HDAC inhibitor in hematological malignant cells". En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/1535-7163.targ-09-a188.
Texto completoKohli, Latika, Steven L. Carroll y Kevin A. Roth. "Abstract A33: Pan erbB inhibition enhances lysosomal dysfunction-induced death in malignant peripheral nerve sheath tumor cells." En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1535-7163.targ-11-a33.
Texto completoThe Van, Trung, Takuya Kuramoto, Hisatsugu Goto, Soji Kakiuchi, Tetsuo Taniguchi, Yoshitaka Sekido, Yasuhiko Nishioka y Saburo Sone. "Abstract B7: TSU‐68 suppresses the progression of malignant pleural mesothelioma cells in SCID mice by inhibiting angiogenesis". En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/1535-7163.targ-09-b7.
Texto completoWelte, Yvonne, Hella Kohlhof, Johann Leban y Christian RA Regenbrecht. "Abstract A59: Wnt, Notch, and Hedgehog pathways as potential therapeutic targets in OCT4A expressing cancer stem cells of malignant melanoma." En Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 12-16, 2011; San Francisco, CA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1535-7163.targ-11-a59.
Texto completoVatansever, D., G. Bildik, C. Taskiran y O. Oktem. "EP1132 A comperative molecular analysis of DNA damage response and apoptosis of malignant granulosa cells after exposure to gemcitabine and cisplatin". En ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.1174.
Texto completoInformes sobre el tema "Malignant Cells - Molecular Characetrization"
Xu, Xiangxi M. A Molecular Basis Accounted for the Malignant Features of Breast Cancer Cells. Fort Belvoir, VA: Defense Technical Information Center, abril de 2012. http://dx.doi.org/10.21236/ada589287.
Texto completoXu, Xiangxi. A Molecular Basis Accounted for the Malignant Features of Breast Cancer Cells. Fort Belvoir, VA: Defense Technical Information Center, octubre de 2011. http://dx.doi.org/10.21236/ada555893.
Texto completo